CDK1 and cervical carcinoma: To summarize our results, 9-oxo-ODAs are expected to inhibit cell proliferation by suppressing the expression of CDK1 and HPV oncoproteins, arresting and reducing the cell cycle of cervical cancer, and inducing partial apoptosis.